Literature DB >> 9694734

The 30-kD domain of protein 4.1 mediates its binding to the carboxyl terminus of pICln, a protein involved in cellular volume regulation.

C J Tang1, T K Tang.   

Abstract

Erythrocyte protein 4.1 (P4.1) is an 80-kD cytoskeletal protein that is important for the maintenance of the structural integrity and flexibility of the red blood cell membrane. Limited chymotryptic digestion of erythroid P4.1 yields 4 structural domains corresponding to the 30-, 16-, 10-, and 22/24-kD domains. Using a yeast two-hybrid system, we isolated cDNA clones encoding pICln that specifically interacts with the 30-kD domain of P4.1. In this report, we show that the carboxyl-terminus (amino acid residues 103-237) of pICln binds to the 30-kD domain of P4.1 in a yeast two-hybrid system. The direct association between the 30-kD domain of P4.1 and pICln was further confirmed by the following findings: (1) the S35-methione-labeled pICln specifically bound to both GST/P4.1-80 (80 kD) and GST/P4.1-30 (30 kD) fusion proteins, but not to the proteins that lack the 30-kD domain; (2) coimmunoprecipitation analysis of the cell extracts from transfected SiHa cells showed that pICln and P4.1 associate in transfected cells. It was reported that pICln can form a complex with actin and may play a role involved in cellular volume regulation. The direct association between P4.1 and pICln suggests that pICln may link P4.1-bound cytoskeletal elements to an unidentified volume-sensitive chloride channel. Copyright 1998 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9694734

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  7 in total

1.  The C-terminus of ICln is natively disordered but displays local structural preformation.

Authors:  Andreas Schedlbauer; Rosaria Gandini; Georg Kontaxis; Markus Paulmichl; Johannes Furst; Robert Konrat
Journal:  Cell Physiol Biochem       Date:  2011-12-16

2.  Inhibition of protein 4.1 R and NuMA interaction by mutagenization of their binding-sites abrogates nuclear localization of 4.1 R.

Authors:  Subhendra N Mattagajasingh; Shu-Ching Huang; Edward J Benz
Journal:  Clin Transl Sci       Date:  2009-04       Impact factor: 4.689

Review 3.  Tumor suppressor role of protein 4.1B/DAL-1.

Authors:  Zi Wang; Ji Zhang; Mao Ye; Min Zhu; Bin Zhang; Mridul Roy; Jing Liu; Xiuli An
Journal:  Cell Mol Life Sci       Date:  2014-09-03       Impact factor: 9.261

4.  The 4.1/ezrin/radixin/moesin domain of the DAL-1/Protein 4.1B tumour suppressor interacts with 14-3-3 proteins.

Authors:  Tingxi Yu; Victoria A Robb; Vinita Singh; David H Gutmann; Irene F Newsham
Journal:  Biochem J       Date:  2002-08-01       Impact factor: 3.857

5.  Protein 4.1 R-135 interacts with a novel centrosomal protein (CPAP) which is associated with the gamma-tubulin complex.

Authors:  L Y Hung; C J Tang; T K Tang
Journal:  Mol Cell Biol       Date:  2000-10       Impact factor: 4.272

6.  The tumor suppressor DAL-1/4.1B and protein methylation cooperate in inducing apoptosis in MCF-7 breast cancer cells.

Authors:  Wei Jiang; Irene F Newsham
Journal:  Mol Cancer       Date:  2006-01-18       Impact factor: 27.401

7.  ICln: a new regulator of non-erythroid 4.1R localisation and function.

Authors:  Claudia Bazzini; Lorena Benedetti; Davide Civello; Chiara Zanoni; Valeria Rossetti; Davide Marchesi; Maria Lisa Garavaglia; Markus Paulmichl; Maura Francolini; Giuliano Meyer; Simona Rodighiero
Journal:  PLoS One       Date:  2014-10-08       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.